Sg Americas Securities, LLC Taro Pharmaceutical Industries LTD Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$40.97 - $43.33 $68,010 - $71,927	-1,660 Reduced 35.52%	3,013 $128,000
Q4 2023 Jan 12, 2024	BUY	$32.77 - $42.31 $30,181 - $38,967	921 Added 24.55%	4,673 $195,000
Q3 2023 Oct 13, 2023	BUY	$35.46 - $40.13 $133,045 - $150,567	3,752 New	3,752 $141,000
Q1 2018 May 03, 2018	SELL	$95.91 - $107.26 $248,598 - $278,017	-2,592 Closed	0 $0
Q4 2017 Jan 24, 2018	SELL	$104.5 - $126.38 $254,353 - $307,608	-2,434 Reduced 48.43%	2,592 $271,000
Q3 2017 Nov 07, 2017	BUY	$97.26 - $116.2 $488,828 - $584,021	5,026	5,026 $566,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.